Delivery Order SPE2DB24D1205-SPE2DB25FCZYA
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,684.93 to AmerisourceBergen Drug Corp for the supply of GVOKE HypoPin 2-pack auto-injectors (0.5mg/0.1ml) with an ultimate completion date of August 18, 2025. This firm fixed-price, non-set-aside contract was awarded competitively on August 15, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. The GVOKE HypoPin is a glucagon emergency injection system used to treat severe hypoglycemia in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack (1 mg/0.2 mL) with a ceiling value of $3,737.84 under a firm fixed price contract type. The delivery order was non-competitive with no set-aside designation and carries an ultimate completion date of August 4, 2025. Performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters. This delivery order is issued as a child...
- The Defense Logistics Agency awarded a delivery order valued at $4,087.62 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This competitively awarded, firm fixed-price contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract involves delivery to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. No set-aside provisions were utilized for this award. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,519.71 to AmerisourceBergen Drug Corp for Gvoke HypoPen 2-Pack 1 mg/0.2 ml auto-injectors. This firm fixed-price, competitively awarded contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order operates as a child contract under AmerisourceBergen's existing indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for GVOKE HypopenTM auto-injector units (2-pack, 1 mg/0.2 mL formulation) with a ceiling value of $19,036.29. This competitively awarded, firm fixed-price delivery order was issued on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The contract specifies performance at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Gvoke HypoPen 2-pack auto-injectors (1 mg/0.2 mL) with a ceiling value of $2,832.92. This is a firm fixed-price delivery order with an ultimate completion date of August 18, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $2,501.51 to AmerisourceBergen Drug Corp for Gvoke HypoPen auto-injectors (1 mg/0.2 mL, 2-pack). This competitive award, issued on July 28, 2025, represents a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. No set-aside designation was applied to this procurement, indicating open competition among eligible...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of GVOKE HypopenPen auto-injectors (2-pack, 1 mg/0.2 ml formulation) with a ceiling value of $1,456.72. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, and performance will be executed from the company's location in Conshohocken, Pennsylvania. The order is set for ultimate completion by August 19, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $9,523.55 to AmerisourceBergen Drug Corp for the supply of Gvoke HypoGen 2-pack auto-injectors (1 mg/0.2 mL) on August 7, 2025, with an ultimate completion date of August 8, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a small-value transaction within...
- The Defense Logistics Agency awarded a $2,522.44 firm fixed price delivery order to AmerisourceBergen Drug Corp for one package of Gvoke HypoGel 1 mg/0.2 mL auto-injector. The order is set to be completed by August 18, 2025, with performance at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a small-value transaction within the company's broader federal pharmaceutical supply portfolio. This...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCZYADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $10,850.43 to AmerisourceBergen Drug Corp for GVOKE HypoPen 2-pack auto-injectors (1 mg/0.2 ml). This firm fixed-price, non-set-aside contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. GVOKE HypoPen is an emergency glucagon auto-injector used to treat severe hypoglycemia in patients with diabetes. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999.9 million and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen supplies a comprehensive range of medications and medical supplies to support military healthcare systems and other federal agencies. The parent IDC enables the company to deliver pharmaceutical products, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Department of Defense medical requirements globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.9k | 8/27/25 |